Is red meat intake a risk factor for breast cancer among premenopausal women?
Vitreo-retinal traction and anastrozole use
Genomic instability demonstrates similarity between DCIS and invasive carcinomas
When genomic and standard test results diverge : Implications for breast cancer patients' preference for chemotherapy
TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro
Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo
BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow
Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases : Data from the EFECT trial
Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)
Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users
Analysis of the effect of age on the prognosis of breast cancer
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
Association between NSAIDs use and breast cancer risk : A systematic review and meta-analysis
Low penetrance breast cancer predisposition SNPs are site specific
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry
Single frequency versus bioimpedance spectroscopy for the assessment of lymphedema
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
Lobular involution : Localized phenomenon or field effect?
Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
Lack of prognostic significance of “classic” lobular breast carcinoma : A matched, single institution series
Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156_157insAlu
MCF-7 breast carcinoma cells do not express caspase-3
Sustained lower rates of breast cancer in the United States
UGT2B7 is not expressed in normal breast